Retraction to: Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation.

Abstract

HomeStrokeVol. 50, No. 8Retraction to: Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation Free AccessRetractionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessRetractionPDF/EPUBRetraction to: Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation Originally published22 Jul 2019https://doi.org/10.1161/STR.0000000000000199Stroke. 2019;50:e245This article is retracted byLong-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial FibrillationThe Editors of Stroke are retracting the following article, “Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation,” (Stroke. 1997;28:2390–2394. doi: 10.1161/01.STR.28.12.2390).An expression of concern was published on April 22, 2019, to alert readers that the American Heart Association | American Stroke Association was communicating with the institution regarding the allegations made about the article.1 An investigation by the Futase Social Insurance Hospital has determined that the study was not approved by the institutional review board, which was not established during the study period. Therefore, the editors are retracting the article.[original article URL: https://www.ahajournals.org/doi/10.1161/01.STR.28.12.2390]